SGLT2 inhibitor empagliflozin remodels pericardial fat–derived lipids-initiated ventricular ion‑channel function to reduce arrhythmogenic electrical remodeling in diabetic hearts
30 August 2026 (14:30 - 14:40)
Organised by: 
Abstract
Slides
About the speaker
Kaohsiung Medical University Hospital, Kaohsiung (Taiwan)
2 More presentations in this session
Ms H. Christensen (DK)
Doctor J. Ostrominski (Boston, US)
Access the full session
The Event
ESC Congress 2026
30 August 2026
14:30 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
30 August 2025
